JPRN-UMIN000012393已完成未知
Diagnostic value of 68Ga-octreotide PET/CT for sarcoidosis - DOTATOC-PET/CT in sarcoidosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Communication disturbance 2. Extremely poor physical status 3. Informed consent not available
研究者
相似试验
进行中（未招募）
不适用
Investigation to understand the significance of a new nuclear medicine imaging technique (68Ga-DOTAOTC PET) for diagnosis of newly diagnosed or recurrent brain tumors originating in the arachnoid membrane (meningiomas)Based on the finding that meningiomas express somatostatin-receptor 2 (SSTR2), PET imaging with SSTR ligands like 68Ga-DOTATOC has been proposed as a more specific method. Currently, the role of SSTR-based imaging for meningioma diagnosis and treatment is still unclear. Therefore the accuracy of MRI and 68Ga-DOTATOC-PET for meningioma diagnosis at initial presentation, to determine residual tumor postoperatively and recurrence during follow-up will be investigated.EUCTR2013-002526-23-ATMedizinische Universität Innsbruck
进行中（未招募）
不适用
Comparison among 68-Ga-labeled octreotide analogues PET, TC and endoscopic ultrasonography in the study of duodeno-pancreatic neuroendocrine tumors.EUCTR2012-000994-22-ITAZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA142
进行中（未招募）
1 期
Prospective evaluation of 68Ga-PSMA PET-CT for Recurrence detection of Prostate Cancer and its impact on patient management. The ProsPERo TrialMales 18 years of age or older with histologically-proven prostate adenocarcinoma and biochemical relapse with rising PSA level after initial treatment with radical curative intent, not yet on palliative systemic treatment and considered for further salvage therapyMedDRA version: 19.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10068979Term: Imaging procedureSystem Organ Class: 10022891 - InvestigationsEUCTR2016-000842-79-BEInstitut Jules Bordet75
招募中
不适用
PSMA-PET/CT in Primary Staging of Prostate CancerNL-OMON28484niversity Medical Center Utrecht100
招募中
不适用
Prospective cross-sectional study of 68Ga-PSMA PET/CT in addition to mpMRI in men undergoing 12-month confirmatory biopsy during Active Surveillance for low- or intermediate-risk prostate cancerCancer - ProstateProstate CancerACTRN12622000188730St. Vincent's Prostate Cancer Research Centre225